TrialThe oncologist2021

Anlotinib, Vincristine, and Irinotecan for Advanced Ewing Sarcoma After Failure of Standard Multimodal Therapy: A Two-Cohort, Phase Ib/II Trial.

Jie Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.